Form 4 for RCUS Arcus Biosciences, Inc.
Accepted 2026-06-12 16:27:48 ET · period of report 2026-06-11 · accession 0001201617-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-12 16:27 | 2026-06-11 | RCUS | PERLMAN ANDREW J | Dir | A - Grant | $0.00 | +5,700 | 48.3K | +13% | $0 |
| D | 2026-06-12 16:27 | 2026-06-11 | RCUS | PERLMAN ANDREW J | Dir | A - Grant | $0.00 | +16.9K | 16.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-11 | A | A | 5,700 | $0.00 | 48,325 | D | — | — | (F1) Represents the grant of restricted stock units that vest in full on the earlier of June 11, 2027 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-06-11 | A | A | 16,900 | $0.00 | 16,900 | D | $23.30 · — to 2036-06-10 | 16,900 Stock Option (Rights to Buy) | (F2) The option will vest in full on the earlier of June 11, 2027 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control. |